CHI3L1 and systemic sclerosis: Consistently, WB and immunofluorescence results demonstrated that anti‐IL‐17RA mAb repressed Chi3L1‐induced myofibroblast differentiation and collagen synthesis in SSc DFs (Figure 6G,H; Figure S12C, Supporting Information).